News headlines about athenahealth (NASDAQ:ATHN) have been trending somewhat positive this week, according to Accern. Accern identifies positive and negative media coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. athenahealth earned a daily sentiment score of 0.18 on Accern’s scale. Accern also gave headlines about the health services provider an impact score of 44.8404202340203 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near term.
These are some of the media stories that may have effected Accern Sentiment Analysis’s rankings:
ATHN stock traded down $5.61 during midday trading on Friday, hitting $138.78. 204,593 shares of the company’s stock were exchanged, compared to its average volume of 446,022. The company has a current ratio of 1.84, a quick ratio of 1.84 and a debt-to-equity ratio of 0.32. The firm has a market cap of $5,564.80, a PE ratio of 88.39, a P/E/G ratio of 2.90 and a beta of 1.13. athenahealth has a one year low of $95.01 and a one year high of $158.66.
athenahealth (NASDAQ:ATHN) last posted its earnings results on Thursday, February 1st. The health services provider reported $1.11 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.63 by $0.48. The firm had revenue of $329.20 million for the quarter, compared to analyst estimates of $319.64 million. athenahealth had a return on equity of 9.21% and a net margin of 4.35%. The company’s revenue for the quarter was up 14.2% on a year-over-year basis. During the same period in the previous year, the company posted $0.62 earnings per share. analysts forecast that athenahealth will post 2.69 earnings per share for the current year.
A number of analysts have commented on the company. Royal Bank of Canada reiterated a “hold” rating and issued a $152.00 price objective on shares of athenahealth in a research report on Friday, February 2nd. BidaskClub downgraded athenahealth from a “sell” rating to a “strong sell” rating in a research report on Saturday, February 3rd. Bank of America initiated coverage on athenahealth in a research report on Tuesday, February 27th. They set a “neutral” rating and a $147.00 target price for the company. SunTrust Banks raised their target price on athenahealth to $180.00 and gave the stock a “buy” rating in a research report on Monday, February 5th. Finally, Piper Jaffray reaffirmed a “buy” rating and set a $160.00 price target on shares of athenahealth in a report on Friday, February 16th. Three analysts have rated the stock with a sell rating, seventeen have assigned a hold rating and seven have issued a buy rating to the company. athenahealth has an average rating of “Hold” and a consensus target price of $144.35.
In other news, CMO Timothy John O’brien sold 3,064 shares of the business’s stock in a transaction dated Friday, March 2nd. The stock was sold at an average price of $137.27, for a total value of $420,595.28. Following the sale, the chief marketing officer now directly owns 11,320 shares in the company, valued at $1,553,896.40. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Jonathan Bush sold 25,000 shares of the business’s stock in a transaction dated Monday, February 5th. The shares were sold at an average price of $145.00, for a total value of $3,625,000.00. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 47,555 shares of company stock worth $6,682,463. Corporate insiders own 3.20% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This news story was originally posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this news story on another domain, it was illegally stolen and republished in violation of U.S. & international copyright legislation. The original version of this news story can be read at https://www.dispatchtribunal.com/2018/04/08/athenahealth-athn-receives-news-impact-score-of-0-18.html.
athenahealth Company Profile
athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.
Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.